The role of chemotherapy in polymorphonuclear phagocytosis in pneumonia

Gioia Piatti, T. Gazzola, L. Allegra

Research output: Contribution to journalArticlepeer-review


The efficacy of the host defense system is a determining factor for the outcome of antimicrobial events in infected patients. The neutrophil granulocyte plays a key role in the lung's defense against bacterial invasion and in the absence of a sufficient attraction of functionally intact neutrophils in the lung, following bacterial challenge, severe pulmonary infection may result. The involvement of phagocytes in pneumonia is well known: infiltration of lung parenchyma by neutrophils occurs within a short time in response to infection and is followed by an influx of monocytes. We investigated the effects of antimicrobial therapy in pneumonia on polymorphonuclear neutrophil (PMN) phagocytosis.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalJournal of Chemotherapy
Issue number3
Publication statusPublished - 1998


  • Antimicrobial chemotherapy
  • Immune defense
  • Phagocytosis
  • Pneumonia
  • Polymorphonuclear cells

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)


Dive into the research topics of 'The role of chemotherapy in polymorphonuclear phagocytosis in pneumonia'. Together they form a unique fingerprint.

Cite this